Haloperidol

氟哌啶醇

Report date: 2026/03/06 20:02:51
NME

Base Information

Drug NameHaloperidol
Drug Alias Name氟呱啶醇氟哌丁苯氟派啶醇SerenaceHaldol +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors modulators
TargetsDopamine receptors
Therapy Area/IndicationsChemotherapy-induced nausea and vomitingSchizophreniaPsychotic Disorders +[7] 
Global Approved IndicationsSchizophreniaPsychotic DisordersBipolar Disorder +[4] 
Approved Indications in ChinaSchizophreniaBipolar DisorderTourette Syndrome
Original Approved Country/TerritoryUnited States
Original Approved Date1967/04/12
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesEssential Pharma LtdMercy Bon Secours Saint Vincent Medical CenterClinigen Ltd +[4] 
Inactive CompaniesNational Institute On Drug AbuseOrtho-Mcneil Pharmaceutical Inc
Active IndicationsChemotherapy-induced nausea and vomitingSchizophreniaBipolar Disorder +[4] 
Inactive IndicationsPsychotic DisordersCocaine-Related DisordersSubstance-Related Disorders

Other Information

ATC CodeN05AD01
Related LinksWikipediaDrugBankKEGG